OKYO

Healthcare Biotechnology

OKYO Pharma Limited

$1.41

-0.02 -1.40% today

Price History

Not enough data

Key Stats

Market Cap

74.00M

Avg Volume

103,764

EPS

-$0.24

52W High

$3.20

52W Low

$1.27

Div. Yield

0.0%

Analyst Ratings

Buy

Str Buy

Buy

Hold

Sell

Str Sell

Valuation

Forward P/E

-2.14

P/B Ratio

6.00

EV/EBITDA

-6.59

Margins

Gross Margin 0.0%

Operating Margin 0.0%

Net Margin 0.0%

EBITDA Margin 0.0%

Growth & Returns

Return on Equity

(263.8%)

Return on Assets

(43.1%)

Liquidity & Leverage

Current Ratio

2.43

Quick Ratio

2.40

Total Cash

20.59M

Total Debt

About

OKYO Pharma Limited, a clinical-stage ophthalmology company, develops therapies for corneal and anterior diseases in the United Kingdom. Its lead clinical product candidate is urcosimod, which is in Phase 2 clinical trials for the treatment of dry eye disease and neuropathic corneal pain. The company is also developing OK-201 for the treatment of acute and chronic ocular pain. OKYO Pharma Limited was incorporated in 2007 and is headquartered in London, the United Kingdom.

okyopharma.com